European Pharmaceutical Review

APRIL 10, 2025

Key findings for UK clinical trials For clinical trials submitted between 2019 and 2023, highlights from the analysis showed that one in eight trials tested treatments in humans for the first time. Furthermore, 85 percent were industry sponsored, marking a strong commercial investment in UK trials.

Pharmacology 52

Pharmacology Medicine Patients Leads 52

Medgadget

MAY 2, 2023

While for other patients the possible adverse side effects from medication may prevent them from finding pharmacological therapies effective. Throughout 2016 and until mid-2019 we conducted a deep technology due diligence, as well as market research, and met and spoke with dozens of mental healthcare providers.

Side effects 86

Side effects Prescription Healthcare Healthcare 86

Pharmaceutical Representative Training

JANUARY 30, 2025

Their role involves presenting complex drug information to healthcare professionals who rely on this knowledge to make informed prescribing decisions. A solid grasp of PK and PD is essential for explaining drug benefits and safety to healthcare professionals. Rang & Dale’s Pharmacology. References ACMALifeSciences.

Pharmacology 52

Pharmacology Side effects Distribution Sales 52

MedCity News

JUNE 16, 2023

The evolution to the new normal Given the evolving climate, Rock Health provided the apt advice as: “rather than aiming to ‘disrupt’ the entire healthcare system, focus is best placed on applying practiced skill sets to top healthcare and research problems.”

Pharma 311

Pharma Food and Drug Administration Recruitment Patients 311

Clarivate

DECEMBER 14, 2023

Here are a few trends in life sciences and healthcare our analysts are keeping an eye on – and what they expect to see in 2024: Move over, oncology – metabolic drugs are the new hotness: The successful launches of Novo Nordisk’s Wegovy® and Eli Lilly’s Mounjaro® represent a revolutionary pharmacological breakthrough of rare proportions.

Pharma 111

Pharma Government Pharmacology Healthcare 111

European Pharmaceutical Review

FEBRUARY 27, 2024

The Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA), Dame June Raine, will step down in the Autumn following five years in the role. Previous roles The MHRA highlighted Dame June Raine has been Chief Executive Officer of the MHRA since August 2019.

Safety 111

Safety Pharmacology Medicine Management 111

European Pharmaceutical Review

MAY 2, 2023

In 2019, the pharmaceutical industry spent $83 billion on R&D, which is about 10 times what the industry spent per year in the 1980s, 4 yet the average duration to develop a new medicine is still around 10-15 years. About the authors Dr Nils Eckardt joined BeiGene in February 2019 as Vice President, Medical Affairs, Europe.

Patients 105

Patients Medicine Marketing Medical 105